When we analyzed c-KIT, and Annexin V double positive cells via flow cytometry, these cells were significantly enhanced by dasatinib and radotinib in BMCs of patients with AML (Fig. 4A). This evidence concerns the gene ANXA5 and acute myeloid leukemia.